Recent Finacing
Recent Raise
Surface Oncology develops next-generation cancer immunotherapies targeting non-checkpoint mechanisms—enhancing antigen presentation, inhibiting tumor-suppressive cells, and neutralizing inhibitory cytokines and metabolites—advancing multiple preclinical programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors